Peter M Chumakov
Overview
Explore the profile of Peter M Chumakov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1967
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sosnovtseva A, Le T, Karpov D, Vorobyev P, Gumennaya Y, Alekseeva O, et al.
Int J Mol Sci
. 2025 Feb;
26(3).
PMID: 39940693
Non-pathogenic natural and recombinant strains of human are the subject of ongoing study with some strains having been approved for use as anticancer agents. The efficacy of oncolytic virotherapy depends...
2.
Alekseeva O, Hoa L, Vorobyev P, Kochetkov D, Gumennaya Y, Naberezhnaya E, et al.
Cancers (Basel)
. 2024 Sep;
16(18).
PMID: 39335111
Enteroviruses, with their diverse clinical manifestations ranging from mild or asymptomatic infections to severe diseases such as poliomyelitis and viral myocarditis, present a public health threat. However, they can also...
3.
Shakiba Y, Vorobyev P, Mahmoud M, Hamad A, Kochetkov D, Yusubalieva G, et al.
Biochemistry (Mosc)
. 2023 Sep;
88(6):823-841.
PMID: 37748878
Cancer virotherapy is an alternative therapeutic approach based on the viruses that selectively infect and kill tumor cells. Vaccinia virus (VV) is a member of the Poxviridae, a family of...
4.
Shakiba Y, Vorobyev P, Yusubalieva G, Kochetkov D, Zajtseva K, Valikhov M, et al.
Mol Ther Oncolytics
. 2023 Jun;
29:158-168.
PMID: 37387795
We developed recombinant variants of oncolytic vaccinia virus LIVP strain expressing interleukin-15 (IL-15) or its receptor subunit alpha (IL-15Rα) to stimulate IL-15-dependent immune cells. We evaluated their oncolytic activity either...
5.
Shakiba Y, Vorobyev P, Naumenko V, Kochetkov D, Zajtseva K, Valikhov M, et al.
Viruses
. 2023 Apr;
15(4).
PMID: 37112810
Oncolytic viral therapy is a promising novel approach to cancer treatment. Oncolytic viruses cause tumor regression through direct cytolysis on the one hand and recruiting and activating immune cells on...
6.
Hamad A, Yusubalieva G, Baklaushev V, Chumakov P, Lipatova A
Viruses
. 2023 Feb;
15(2).
PMID: 36851761
Glioblastoma is the most aggressive form of malignant brain tumor. Standard treatment protocols and traditional immunotherapy are poorly effective as they do not significantly increase the long-term survival of glioblastoma...
7.
Vorobyev P, Kochetkov D, Chumakov P, Zakirova N, Zotova-Nefedorova S, Vasilenko K, et al.
Cancers (Basel)
. 2022 Nov;
14(22).
PMID: 36428704
Glioblastoma multiforme (GBM) is one of the most common types of brain tumor. Despite intensive research, patients with GBM have a poor prognosis due to a very high rate of...
8.
Nikitina A, Lipatova A, Goncharov A, Kliuchnikova A, Pyatnitskiy M, Kuznetsova K, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563635
Cancer cell lines responded differentially to type I interferon treatment in models of oncolytic therapy using vesicular stomatitis virus (VSV). Two opposite cases were considered in this study, glioblastoma DBTRG-05MG...
9.
Lipatova A, Soboleva A, Gorshkov V, Bubis J, Solovyeva E, Krasnov G, et al.
Cancers (Basel)
. 2021 Nov;
13(21).
PMID: 34771433
Oncolytic viruses have gained momentum in the last decades as a promising tool for cancer treatment. Despite the progress, only a fraction of patients show a positive response to viral...
10.
Kovaleva I, Tokarchuk A, Zheltukhin A, Dalina A, Safronov G, Evstafieva A, et al.
PLoS One
. 2020 Apr;
15(4):e0226862.
PMID: 32287270
SESN2 is a member of the evolutionarily conserved sestrin protein family found in most of the Metazoa species. The SESN2 gene is transcriptionally activated by many stress factors, including metabolic...